After the Update the WaitingMarket got a glimpse of what going with PII.
Basically we wait a few more weeks.
GBM is very vulnerable to anti-cancerous agent, so anything would do the work. The awful side of anti-cancerous agent is that they have side-effects. In this case, side effects direclty to the BRAIN.
Luckily 4601 has no side-effects to report. Molecule is very small 464 daltons. IT should do the work nicely.
Of the 20 patients recruited, a percentage finish the 6 months already. So Thallion has some results already.
The other argument supporting this point of view is that if they know about side-effect, they know something about efficacy.
Why suggest a sub-group now unless you have a sub-group to suggest?
Seagal is lay down the ground works for the next by suggesting multiple application for 4601 as he is trying to get a good takeover price a lucrative licensing deal or a lucrative partnership deal.
Efficacy without side-effect is better than gold for anti-cancer agent. This is a golden attribute.
PS:
Post have been removed because of offensive nature. I would like to apologized for my anti-homo humor.
Pepman there is nothing wrong for being what you are. Nothing wrong.
Stock trading is for real men but can also include other "orientation". Again nothing wrong with being yourself.